Edgewell Personal Care CO Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
Edgewell Personal Care Company director Swan Sit acquired 7,817 restricted stock equivalents, aligning interests with shareholders.
NYSE
Edgewell Personal Care Co. Director Rakesh Sachdev was granted 7,817 restricted stock equivalents, enhancing his beneficial ownership.
NYSE
Edgewell Personal Care Co. Director Stephanie Stahl acquired 7,817 restricted stock equivalents, converting to common stock, as part of her compensation.
NYSE
Edgewell Personal Care Co. Director John C Hunter III was granted 7,817 restricted stock equivalents, aligning his interests with shareholders.
NYSE
Edgewell Personal Care Co. director George Corbin was granted 7,817 restricted stock equivalents, converting to common stock on a future date.
NYSE
Edgewell Personal Care Director Gary Waring was granted 7,817 restricted stock equivalents, convertible into common stock.
NYSE
Edgewell Personal Care Co. Director Carla C. Hendra was granted 7,817 restricted stock equivalents.
NYSE
Edgewell Personal Care Co. Director Robert William Black acquired 7,817 restricted stock equivalents, aligning his interests with shareholders.
NYSE
Edgewell Personal Care CFO Francesca Weissman reported the vesting of 2,296 restricted stock equivalents and the subsequent withholding of 798 shares for tax obligations.
NYSE
Edgewell Personal Care's Chief Accounting Officer, John M. Dunham, reported the sale of 333 shares of common stock at $17.21 per share.
NYSE
Paul Hibbert, Edgewell Personal Care's Chief Supply Chain Officer, reported the vesting of performance stock equivalents and the grant of new restricted stock equivalents.
NYSE
Edgewell Personal Care CEO Rod R. Little reported the vesting of performance stock equivalents, a tax-related share disposition, and a new grant of restricted stock equivalents.
NYSE
Edgewell Personal Care's Chief People & Legal Officer, LaTanya Langley, reported vesting of performance stock and acquisition of new restricted stock equivalents.
NYSE
Edgewell Personal Care CFO Francesca Weissman reported the vesting of performance stock and a new grant of restricted stock equivalents.
NYSE
Edgewell Personal Care Co. President, North America, Jessica Spence, was granted 26,476 restricted stock units vesting over three years.
NYSE
Edgewell Personal Care Co. granted 3,586 Restricted Stock Equivalents to Chief Accounting Officer John M. Dunham, vesting over three years.
NYSE
Edgewell Personal Care's Chief Supply Chain Officer, Paul Hibbert, reported the vesting of restricted stock equivalents and subsequent sales to cover tax liabilities.
NYSE
Edgewell Personal Care's Chief People & Legal Officer, LaTanya Langley, reported routine transactions involving the vesting of restricted stock equivalents and subsequent share withholding for tax obligations.
NYSE
Edgewell Personal Care's Chief Accounting Officer, John M. Dunham, reported the acquisition of 461 common shares and the disposition of 128 shares for tax purposes.
NYSE
Edgewell Personal Care CEO Rod Little reported routine transactions involving the vesting of restricted stock equivalents and subsequent tax-related share dispositions.
NYSE
Edgewell Personal Care Co's CFO, Francesca Weissman, reported the vesting of restricted stock equivalents and subsequent tax-related share dispositions.
NYSE
Jessica Spence, President of North America for Edgewell Personal Care, reported the vesting of restricted stock equivalents and subsequent share dispositions for tax liabilities on November 8, 2025.
NYSE
Edgewell Personal Care's Chief Operating Officer, Daniel Sullivan, departed the company on October 1, 2025, resulting in the forfeiture of unvested equity awards and a 90-day window to exercise vested options.
NYSE
Director Swan Sit acquired 4,999 restricted stock equivalents in Edgewell Personal Care Co on February 6, 2025, convertible into common stock.
NYSE
Director Carla C. Hendra reports acquiring 4,999 restricted stock equivalents convertible to Edgewell Personal Care Co [EPC] common stock.
NYSE
Director Gary Waring acquired 4,999 restricted stock equivalents of Edgewell Personal Care on February 6, 2025, convertible into common stock.
NYSE
Director John C Hunter III reports acquiring 4,999 restricted stock equivalents of Edgewell Personal Care Co on February 6, 2025.
NYSE
Director George Corbin acquired 4,999 restricted stock equivalents in Edgewell Personal Care Co on February 6, 2025.
NYSE
Director Stahl Stephanie reports acquiring 4,999 restricted stock equivalents convertible to Edgewell Personal Care Co [EPC] common stock.
NYSE
Director James C. Johnson reports acquisition of 4,999 restricted stock equivalents convertible to Edgewell Common Stock.